ACCESS Newswire Inc. ACCS
DESCRIPTION OF BUSINESS.
its subsidiaries are hereinafter collectively referred to as "ACCESS", "ACCESS Newswire", the "Company",
"We" or "Our" unless otherwise noted.
formed in October 1988 under the name Docucon Incorporated. In December 2007, we changed our name to Issuer Direct Corporation,
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $22.6M | $23.1M | $24.5M | $23.5M | $21.9M | $18.5M | $16.3M | $14.2M | $12.6M | $12.1M |
| Cost of revenue | $5.3M | $5.6M | $5.6M | $5.7M | $5.7M | $5.4M | $5.1M | $4.1M | $3.4M | $3.0M |
| Gross profit | $17.3M | $17.4M | $18.9M | $17.8M | $16.1M | $13.1M | $11.2M | $10.1M | $9.2M | $9.0M |
| R&D | $2.7M | $2.8M | $2.5M | $1.3M | $1.1M | $825.0K | $1.2M | $1.3M | $763.0K | $404.0K |
| SG&A | $7.2M | $7.0M | $8.4M | $7.0M | $5.8M | $5.0M | $5.1M | $4.1M | $3.4M | $3.2M |
| Total operating expenses | $19.2M | $33.8M | — | $15.2M | $12.4M | $10.4M | $10.7M | $9.0M | $7.2M | $7.1M |
| Operating income | -$1.9M | -$16.3M | -$2.7M | $2.7M | $3.7M | $2.7M | $474.0K | $1.2M | $2.0M | $1.9M |
| Interest expense | $2.0K | $1.1M | $1.2M | $11.0K | $3.0K | $56.0K | $321.0K | $47.0K | $2.0K | $4.0K |
| Pre-tax income | -$2.0M | -$17.3M | -$4.4M | $2.7M | $4.1M | $451.0K | $795.0K | $1.2M | $2.0M | $2.0M |
| Income tax | $395.0K | $4.1M | $938.0K | $724.0K | $821.0K | $724.0K | $109.0K | $373.0K | $131.0K | $464.0K |
| Net income | $4.3M | -$10.8M | $766.0K | $1.9M | $3.3M | $2.1M | $686.0K | $837.0K | $1.9M | $1.6M |
| EPS, basic | 1.11 | -2.82 | 0.20 | 0.52 | 0.87 | 0.56 | 0.18 | 0.25 | 0.63 | 0.55 |
| EPS, diluted | 1.11 | -2.82 | 0.20 | 0.52 | 0.86 | 0.56 | 0.18 | 0.24 | 0.62 | 0.54 |
| Shares, diluted (wtd. avg.) | 3.9M | 3.8M | 3,816 | 3.7M | 3.8M | 3.8M | 3,861 | 3.5M | 3.0M | 2.9M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $3.0M | $4.1M | $5.7M | $4.8M | $23.9M | $19.6M | $15.8M | $17.2M | $4.9M | $5.3M |
| Receivables | $3.9M | $3.4M | $3.0M | $3.0M | — | — | — | — | — | — |
| Total current assets | $8.4M | $10.0M | $11.5M | $9.4M | $27.9M | $22.4M | $18.0M | $19.0M | $7.1M | $6.8M |
| Property, plant and equipment | $136.0K | $365.0K | $495.0K | $625.0K | $713.0K | $795.0K | $899.0K | $132.0K | $145.0K | $204.0K |
| Goodwill | $19.0M | $19.0M | $19.0M | $22.5M | $6.4M | $6.4M | $6.4M | $5.0M | $4.1M | $2.2M |
| Other intangibles | $9.5M | $12.0M | $28.7M | $32.2M | $2.4M | $2.9M | $3.5M | $2.8M | $2.9M | $1.4M |
| Total assets | $42.0M | $50.6M | $65.2M | $66.3M | $39.3M | $34.9M | $32.4M | $29.0M | $16.9M | $12.9M |
| Accounts payable | $1.5M | $1.4M | $1.2M | $1.4M | $695.0K | $304.0K | $266.0K | $371.0K | $666.0K | $343.0K |
| Short-term debt | $870.0K | $4.0M | $4.0M | $22.0M | — | — | — | — | — | — |
| Total current liabilities | $9.5M | $12.8M | $12.7M | $31.2M | $5.8M | $4.6M | $3.8M | $2.6M | $2.5M | $2.1M |
| Long-term debt | $1.7M | $11.9M | $15.9M | $0 | — | — | — | — | — | — |
| Total liabilities | $11.6M | $25.4M | $29.7M | $33.1M | $7.6M | $6.7M | $6.3M | $3.3M | $3.7M | $2.3M |
| Retained earnings | $5.4M | $1.1M | $11.9M | $11.2M | $9.2M | $5.9M | $3.8M | $3.2M | $2.8M | $1.5M |
| Total equity | $30.3M | $25.2M | $35.4M | $33.2M | $31.6M | $28.1M | $26.1M | $25.7M | $13.2M | $10.6M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $558.0K | $3.2M | $3.1M | $4.0M | $4.7M | $4.4M | $2.9M | $2.9M | $2.5M | $2.8M |
| Depreciation and amortisation | $3.0M | $3.1M | $2.8M | $1.0M | $1.1M | $1.3M | $1.7M | $1.4M | $735.0K | $1.1M |
| Stock-based compensation | $884.0K | $684.0K | $1.4M | $763.0K | $333.0K | $273.0K | $523.0K | $629.0K | $516.0K | $592.0K |
| Capital expenditure | $20.0K | $19.0K | $25.0K | $66.0K | $62.0K | $27.0K | $420.0K | $51.0K | $11.0K | $112.0K |
| Investing cash flow | $11.8M | -$616.0K | -$153.0K | -$18.0M | -$277.0K | -$27.0K | -$3.2M | -$1.2M | -$2.8M | -$1.2M |
| Financing cash flow | -$13.6M | -$4.0M | -$2.1M | -$4.9M | -$146.0K | -$574.0K | -$1.1M | $10.7M | -$199.0K | -$418.0K |
| Dividends paid | — | — | — | $0 | $0 | $0 | $0 | $460.0K | $588.0K | $453.0K |
| Buybacks | — | — | $0 | $5.0M | $453.0K | $785.0K | $773.0K | $2.6M | $0 | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001683168-26-003382.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.1M | $12.6M | $14.2M | $16.3M | $18.5M | $21.9M | $23.5M | $24.5M | $23.1M | $22.6M |
| Gross profit | $9.0M | $9.2M | $10.1M | $11.2M | $13.1M | $16.1M | $17.8M | $18.9M | $17.4M | $17.3M |
| Net income | $1.6M | $1.9M | $837.0K | $686.0K | $2.1M | $3.3M | $1.9M | $766.0K | -$10.8M | $4.3M |
Recent filings and events
- Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Results announced Item 2.02
- Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
- Results announced Item 2.02
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
- Results announced Item 2.02
- Results announced Item 2.02
- Shareholder vote Item 5.07
- Results announced Item 2.02
- Results announced Item 2.02
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 8742
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| BAH | Booz Allen Hamilton Holding Corp | $9.42B | 11.4x | -6.4% |
| G | Genpact LTD | $6.86B | 13.0x | 6.6% |
| FCN | FTI CONSULTING, INC | $4.34B | 19.1x | 2.4% |
| EXPO | EXPONENT INC | $3.68B | 37.4x | 4.2% |
| HURN | Huron Consulting Group Inc. | $3.17B | 33.5x | 11.9% |
| ASTH | Astrana Health, Inc. | $2.09B | 81.4x | 56.4% |
| ICFI | ICF International, Inc. | $1.69B | 19.1x | -7.3% |
| BWMN | Bowman Consulting Group Ltd. | $742.5M | 58.7x | 14.9% |